BIOMAT Database Logo BIOMAT Database Logo

Expression of c-erbB-2 gene product in urinary bladder cancer. 1991

M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Department of Pathology and Oncology, Institute of Medical Science, University of Tokyo, Japan.

Expression of the c-erbB-2 gene product and the epidermal growth factor receptor (EGF-R) was investigated in 54 cases of human bladder cancer immunohistologically and by Western blot analysis. For detection of the c-erbB-2 product, two specific antibodies, a rabbit polyclonal antibody directed to the intracellular domain and a murine monoclonal antibody recognizing an epitope in the extracellular domain, were used. Seventeen cases of bladder cancer were stained by the anti-c-erbB-2 polyclonal antibody, while 20 cases were stained by the monoclonal antibody, with good correlation on both stainings (p less than 0.01). There were four c-erbB-2 positive cases in 26 G1 tumors, four in 15 G2 tumors, and nine in 13 G3 tumors. There were also eight erbB-2 positive cases in nine muscle-invasive tumors, nine of 45 superficial tumors, four of five with lymph node metastasis, and seven of 14 without metastasis, as revealed by staining with the polyclonal antibody. Thus, the c-erbB-2 gene product was more frequently expressed in high grade tumors (p less than 0.01), in high stage tumors (p less than 0.01), and nodal metastatic tumors (N.S. by Chi-square test). Twenty-two of the 54 tumors were stained by an anti-EGF-R monoclonal antibody, 528 IgG. The expression of EGF-R was independent of histological grading, tumor stage, and nodal status, and no correlation was observed between expression of the c-erbB-2 product and EGF-R. The c-erbB-2 product may be applicable as a tumor marker for evaluation of malignant potential, invasiveness, and probably metastatic potential of human bladder cancer.

UI MeSH Term Description Entries
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D066246 ErbB Receptors A family of structurally related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS. EGF Receptor,Epidermal Growth Factor Receptor,Epidermal Growth Factor Receptor Family Protein,Epidermal Growth Factor Receptor Protein-Tyrosine Kinase,ErbB Receptor,HER Family Receptor,Receptor, EGF,Receptor, Epidermal Growth Factor,Receptor, TGF-alpha,Receptor, Transforming-Growth Factor alpha,Receptor, Urogastrone,Receptors, Epidermal Growth Factor-Urogastrone,TGF-alpha Receptor,Transforming Growth Factor alpha Receptor,Urogastrone Receptor,c-erbB-1 Protein,erbB-1 Proto-Oncogene Protein,EGF Receptors,Epidermal Growth Factor Receptor Family Proteins,Epidermal Growth Factor Receptor Kinase,HER Family Receptors,Proto-oncogene c-ErbB-1 Protein,Receptor Tyrosine-protein Kinase erbB-1,Receptor, ErbB-1,Receptors, Epidermal Growth Factor,Epidermal Growth Factor Receptor Protein Tyrosine Kinase,ErbB-1 Receptor,Family Receptor, HER,Family Receptors, HER,Proto oncogene c ErbB 1 Protein,Proto-Oncogene Protein, erbB-1,Receptor Tyrosine protein Kinase erbB 1,Receptor, ErbB,Receptor, ErbB 1,Receptor, HER Family,Receptor, TGF alpha,Receptor, Transforming Growth Factor alpha,Receptors, EGF,Receptors, Epidermal Growth Factor Urogastrone,Receptors, ErbB,Receptors, HER Family,c erbB 1 Protein,c-ErbB-1 Protein, Proto-oncogene,erbB 1 Proto Oncogene Protein

Related Publications

M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Expression of c-erbB-2 protein product in bladder cancer.
November 1990, British journal of cancer,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Expression of the c-erbB-3 gene product in gastric cancer.
July 1993, International journal of cancer,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
[p16, p53 and c-erbB-2 gene expression in bladder carcinoma].
February 2000, Zhonghua bing li xue za zhi = Chinese journal of pathology,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Immunohistochemical analysis of c-erbB-2 oncogene product and epidermal growth factor receptor expression in human urinary bladder carcinomas.
May 1990, Acta pathologica japonica,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
July 2000, Histology and histopathology,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer.
January 1993, European journal of cancer (Oxford, England : 1990),
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Expression of the c-erbB-2 gene product as detected in cytologic aspirates in breast cancer.
January 1993, Acta cytologica,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
c-erbB-2 gene product associates with catenins in human cancer cells.
November 1994, Biochemical and biophysical research communications,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
Detection of the c-myc gene product in urinary bladder cancer.
December 1990, Japanese journal of cancer research : Gann,
M Moriyama, and T Akiyama, and T Yamamoto, and T Kawamoto, and T Kato, and K Sato, and T Watanuki, and T Hikage, and N Katsuta, and S Mori
[c-erbB-2 oncogene product expression in lacrimal gland tumors].
July 1994, Nippon Ganka Gakkai zasshi,
Copied contents to your clipboard!